Cargando…

T91. THE POSITIVE AND NEGATIVE SYNDROME SCALE SUPERIOR TO A SELF-REPORT QUESTIONNAIRE IN THE PHARMACOTHERAPY MONITORING AND OUTCOME SURVEY

BACKGROUND: Aiming to improve the quality of care for patients with a psychotic disorder, the ongoing Pharmacotherapy Monitoring Outcome Survey (PHAMOUS) started in 2006 in four large mental health care organizations in the Northern Netherlands, by adding it to the at that time mandatory Routine Out...

Descripción completa

Detalles Bibliográficos
Autores principales: Bartels-Velthuis, Annegien, Ties, Koen, Visser, Ellen, Arends, Johan, Pijnenborg, Marieke, Wunderink, Lex, Jörg, Frederike, Veling, Wim, Castelein, Stynke, Knegtering, Henderikus, Bruggeman, Richard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7234546/
http://dx.doi.org/10.1093/schbul/sbaa029.651
_version_ 1783535788679495680
author Bartels-Velthuis, Annegien
Ties, Koen
Visser, Ellen
Arends, Johan
Pijnenborg, Marieke
Wunderink, Lex
Jörg, Frederike
Veling, Wim
Castelein, Stynke
Knegtering, Henderikus
Bruggeman, Richard
author_facet Bartels-Velthuis, Annegien
Ties, Koen
Visser, Ellen
Arends, Johan
Pijnenborg, Marieke
Wunderink, Lex
Jörg, Frederike
Veling, Wim
Castelein, Stynke
Knegtering, Henderikus
Bruggeman, Richard
author_sort Bartels-Velthuis, Annegien
collection PubMed
description BACKGROUND: Aiming to improve the quality of care for patients with a psychotic disorder, the ongoing Pharmacotherapy Monitoring Outcome Survey (PHAMOUS) started in 2006 in four large mental health care organizations in the Northern Netherlands, by adding it to the at that time mandatory Routine Outcome Monitoring program. However, since the cuts in the financial budgets for mental health care, research nurses are increasingly experiencing time-pressure in the assessments. The Positive and Negative Syndrome Scale (PANSS), part of the assessment, is a time-consuming interview, taking approximately 30 minutes. Therefore, we developed and validated a short self-report questionnaire assessing positive psychotic symptoms, the Brief Positive Symptoms Questionnaire (BPSQ). METHODS: The BPSQ was added to PHAMOUS and filled in once by patients in four mental health care institutions in 2017 and 2018. The BPSQ consists of nine items and takes about 2–3 minutes to complete. It was validated against the PANSS positive scale and two items of the Health of the Nations Outcome Scale (HoNOS), with item 6 assessing the problems that patients experience due to hallucinations and delusions and item 8 assessing further mental and behavioural problems. RESULTS: BPSQ data were obtained from n=287 patients (mean age 47.1 years, 67.6% male). The PANSS was assessed in n=244 and HoNOS data were available for n=156 patients. Scores of one patient were considered unreliable and thus removed from the data set. The BPSQ had a Cronbach’s alpha of .81. Spearman’s correlation coefficient of the BPSQ and the PANSS positive scale was significant (ρ(243) = .63, p < .05). Correlations between the BPSQ and HoNOS items 6 and 8 were significant (ρ(155) = .488, p < .05 and ρ(155) = .251, p < .05 respectively). Post hoc analysis showed that the more severely psychotic the patients were, the less the BPSQ and the PANSS positive scale were corresponding. DISCUSSION: Given the medium correlation of the BPSQ with the PANSS positive scale and the low concurrent validity with the two relevant HoNOS items, we argue that the widely used and validated PANSS is indispensable in the PHAMOUS assessment of positive symptoms in a chronic population with psychotic disorders. Replication of this study in first-episode psychotic patients is recommended.
format Online
Article
Text
id pubmed-7234546
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-72345462020-05-23 T91. THE POSITIVE AND NEGATIVE SYNDROME SCALE SUPERIOR TO A SELF-REPORT QUESTIONNAIRE IN THE PHARMACOTHERAPY MONITORING AND OUTCOME SURVEY Bartels-Velthuis, Annegien Ties, Koen Visser, Ellen Arends, Johan Pijnenborg, Marieke Wunderink, Lex Jörg, Frederike Veling, Wim Castelein, Stynke Knegtering, Henderikus Bruggeman, Richard Schizophr Bull Poster Session III BACKGROUND: Aiming to improve the quality of care for patients with a psychotic disorder, the ongoing Pharmacotherapy Monitoring Outcome Survey (PHAMOUS) started in 2006 in four large mental health care organizations in the Northern Netherlands, by adding it to the at that time mandatory Routine Outcome Monitoring program. However, since the cuts in the financial budgets for mental health care, research nurses are increasingly experiencing time-pressure in the assessments. The Positive and Negative Syndrome Scale (PANSS), part of the assessment, is a time-consuming interview, taking approximately 30 minutes. Therefore, we developed and validated a short self-report questionnaire assessing positive psychotic symptoms, the Brief Positive Symptoms Questionnaire (BPSQ). METHODS: The BPSQ was added to PHAMOUS and filled in once by patients in four mental health care institutions in 2017 and 2018. The BPSQ consists of nine items and takes about 2–3 minutes to complete. It was validated against the PANSS positive scale and two items of the Health of the Nations Outcome Scale (HoNOS), with item 6 assessing the problems that patients experience due to hallucinations and delusions and item 8 assessing further mental and behavioural problems. RESULTS: BPSQ data were obtained from n=287 patients (mean age 47.1 years, 67.6% male). The PANSS was assessed in n=244 and HoNOS data were available for n=156 patients. Scores of one patient were considered unreliable and thus removed from the data set. The BPSQ had a Cronbach’s alpha of .81. Spearman’s correlation coefficient of the BPSQ and the PANSS positive scale was significant (ρ(243) = .63, p < .05). Correlations between the BPSQ and HoNOS items 6 and 8 were significant (ρ(155) = .488, p < .05 and ρ(155) = .251, p < .05 respectively). Post hoc analysis showed that the more severely psychotic the patients were, the less the BPSQ and the PANSS positive scale were corresponding. DISCUSSION: Given the medium correlation of the BPSQ with the PANSS positive scale and the low concurrent validity with the two relevant HoNOS items, we argue that the widely used and validated PANSS is indispensable in the PHAMOUS assessment of positive symptoms in a chronic population with psychotic disorders. Replication of this study in first-episode psychotic patients is recommended. Oxford University Press 2020-05 2020-05-18 /pmc/articles/PMC7234546/ http://dx.doi.org/10.1093/schbul/sbaa029.651 Text en © The Author(s) 2020. Published by Oxford University Press on behalf of the Maryland Psychiatric Research Center. http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Poster Session III
Bartels-Velthuis, Annegien
Ties, Koen
Visser, Ellen
Arends, Johan
Pijnenborg, Marieke
Wunderink, Lex
Jörg, Frederike
Veling, Wim
Castelein, Stynke
Knegtering, Henderikus
Bruggeman, Richard
T91. THE POSITIVE AND NEGATIVE SYNDROME SCALE SUPERIOR TO A SELF-REPORT QUESTIONNAIRE IN THE PHARMACOTHERAPY MONITORING AND OUTCOME SURVEY
title T91. THE POSITIVE AND NEGATIVE SYNDROME SCALE SUPERIOR TO A SELF-REPORT QUESTIONNAIRE IN THE PHARMACOTHERAPY MONITORING AND OUTCOME SURVEY
title_full T91. THE POSITIVE AND NEGATIVE SYNDROME SCALE SUPERIOR TO A SELF-REPORT QUESTIONNAIRE IN THE PHARMACOTHERAPY MONITORING AND OUTCOME SURVEY
title_fullStr T91. THE POSITIVE AND NEGATIVE SYNDROME SCALE SUPERIOR TO A SELF-REPORT QUESTIONNAIRE IN THE PHARMACOTHERAPY MONITORING AND OUTCOME SURVEY
title_full_unstemmed T91. THE POSITIVE AND NEGATIVE SYNDROME SCALE SUPERIOR TO A SELF-REPORT QUESTIONNAIRE IN THE PHARMACOTHERAPY MONITORING AND OUTCOME SURVEY
title_short T91. THE POSITIVE AND NEGATIVE SYNDROME SCALE SUPERIOR TO A SELF-REPORT QUESTIONNAIRE IN THE PHARMACOTHERAPY MONITORING AND OUTCOME SURVEY
title_sort t91. the positive and negative syndrome scale superior to a self-report questionnaire in the pharmacotherapy monitoring and outcome survey
topic Poster Session III
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7234546/
http://dx.doi.org/10.1093/schbul/sbaa029.651
work_keys_str_mv AT bartelsvelthuisannegien t91thepositiveandnegativesyndromescalesuperiortoaselfreportquestionnaireinthepharmacotherapymonitoringandoutcomesurvey
AT tieskoen t91thepositiveandnegativesyndromescalesuperiortoaselfreportquestionnaireinthepharmacotherapymonitoringandoutcomesurvey
AT visserellen t91thepositiveandnegativesyndromescalesuperiortoaselfreportquestionnaireinthepharmacotherapymonitoringandoutcomesurvey
AT arendsjohan t91thepositiveandnegativesyndromescalesuperiortoaselfreportquestionnaireinthepharmacotherapymonitoringandoutcomesurvey
AT pijnenborgmarieke t91thepositiveandnegativesyndromescalesuperiortoaselfreportquestionnaireinthepharmacotherapymonitoringandoutcomesurvey
AT wunderinklex t91thepositiveandnegativesyndromescalesuperiortoaselfreportquestionnaireinthepharmacotherapymonitoringandoutcomesurvey
AT jorgfrederike t91thepositiveandnegativesyndromescalesuperiortoaselfreportquestionnaireinthepharmacotherapymonitoringandoutcomesurvey
AT velingwim t91thepositiveandnegativesyndromescalesuperiortoaselfreportquestionnaireinthepharmacotherapymonitoringandoutcomesurvey
AT casteleinstynke t91thepositiveandnegativesyndromescalesuperiortoaselfreportquestionnaireinthepharmacotherapymonitoringandoutcomesurvey
AT knegteringhenderikus t91thepositiveandnegativesyndromescalesuperiortoaselfreportquestionnaireinthepharmacotherapymonitoringandoutcomesurvey
AT bruggemanrichard t91thepositiveandnegativesyndromescalesuperiortoaselfreportquestionnaireinthepharmacotherapymonitoringandoutcomesurvey